The Scorecard: 2 Month Update: ONTO Sell — Correct so far

Revisiting our Sell call on ONTO: entry $319.32, latest $258.90, -18.9%.

This is a Scorecard review, revisiting a past LF0 research call against what actually happened.

Ticker: ONTO Rating: Sell Published: 2026-07-14 Checkpoint: 2026-09-14 Entry price: $319.32 Latest price: $258.90 as of 2026-09-14 Stock return since entry: -18.9% Signal return: +18.9% Verdict: Correct so far

This is the 2-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.

Read the original LF0 analysis

What I Said

I said ONTO was priced for a better earnings path than its latest quarter and peer setup justified, even though I acknowledged the business has a moat, a strong balance sheet, and healthy gross margins. My concern was that customer concentration, tariff exposure, and export controls were slowing the conversion of that strength into operating profit, while the 54.2x EV/EBITDA multiple and 1.2% FCF yield left little room for disappointment.

Peer Comparison

CompanyReturn Since Entry
ONTO (this call)-18.9%
AMAT-28.0%
ASML-10.1%
KLAC-26.3%
LRCX-20.0%
NVMI-28.3%

Why It’s Working (Or Not)

So far, a short would have earned about 18.9% from my entry, so the Sell call has been directionally right. The stock has fallen while the peer group has also been broadly weaker, which means my thesis has not been uniquely proven by a relative-strength collapse, but it has still been supported by the market’s willingness to reprice the name lower. The specific valuation concern I highlighted has held up better than the bullish case: the market has not rewarded the moat and balance sheet enough to offset the execution and policy risks I named. I still cannot claim the full thesis is finished, but the evidence so far says the burden of proof remains on management, not on me.

What Could Still Prove Me Wrong

What could still prove me wrong is a sustained re-acceleration in revenue above 15% for two straight quarters, paired with operating margin moving into the high teens, because that would show the earnings rebound is durable rather than temporary. I would also have to reconsider if customer concentration, tariff exposure, and export controls stop meaningfully constraining profitability and the company starts converting gross margin strength into stronger operating income. If growth slips back below 8% for two straight quarters or earnings stay weak while the stock stabilizes at a much richer valuation, that would reinforce my original Sell.

The July 2026 Cohort

Other directional calls published the same month:

TickerRatingEntryLatestStock ReturnSignal ReturnVerdict
NLSTSell$2.44$4.79+96.3%-96.3%Incorrect so far
BMNRSell$17.74$25.20+42.1%-42.1%Incorrect so far
RDWSell$8.99$10.60+17.9%-17.9%Incorrect so far
QUBTSell$7.43$7.97+7.2%-7.2%Incorrect so far
FTNTSell$156.25$164.10+5.0%-5.0%Incorrect so far
VSATSell$69.54$71.90+3.4%-3.4%Incorrect so far
RCATSell$7.83$7.89+0.8%-0.8%Incorrect so far
MARASell$11.67$11.61-0.5%+0.5%Correct so far
HUTSell$98.33$91.61-6.8%+6.8%Correct so far
SMRStrong Sell$8.81$8.40-4.6%+6.9%Correct so far
TPLSell$408.26$371.00-9.1%+9.1%Correct so far
AMBASell$72.90$65.31-10.4%+10.4%Correct so far
TTWOSell$247.62$217.04-12.3%+12.3%Correct so far
AMKRSell$60.60$48.33-20.2%+20.2%Correct so far
UANBuy$110.58$136.47+23.4%+23.4%Correct so far
CIFRSell$21.85$16.18-25.9%+25.9%Correct so far
MYRGSell$391.51$279.39-28.6%+28.6%Correct so far
FLNCSell$14.42$9.60-33.4%+33.4%Correct so far
MTZSell$380.63$232.15-39.0%+39.0%Correct so far

Live LF0 scorecard: The Scorecard | Research Performance dashboard

Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.

Research disclaimer

This material is provided for research and educational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any security or strategy.

New stock analysis in your inbox.

Independent equity research on under-the-radar companies from lf0 — free, when new work publishes.




No spam. Unsubscribe anytime.

Prefer Substack? Follow lf0 Research on Substack

Leave a Comment

Your email address will not be published. Required fields are marked *